» Articles » PMID: 35854181

CRISPR-Cas Systems: Role in Cellular Processes Beyond Adaptive Immunity

Overview
Publisher Springer
Specialty Microbiology
Date 2022 Jul 19
PMID 35854181
Authors
Affiliations
Soon will be listed here.
Abstract

Clustered regularly interspaced short palindromic repeats and associated Cas proteins (CRISPR-Cas) are the only known adaptive immune system in prokaryotes. CRISPR-Cas system provides sequence-specific immunity against invasion by foreign genetic elements. It carries out its functions by incorporating a small part of the invading DNA sequence, termed as spacer into the CRISPR array. Although the CRISPR-Cas systems are mainly responsible for adaptive immune functions, their alternative role in the gene regulation, bacterial pathophysiology, virulence, and evolution has started to unravel. In several species, these systems are revealed to regulate the processes beyond adaptive immunity by employing various components of CRISPR-Cas machinery, independently or in combination. The molecular mechanisms entailing the regulatory processes are not clear in most of the instances. In this review, we have discussed some well-known and some recently established noncanonical functions of CRISPR-Cas system and its fast-extending applications in other biological processes.

Citing Articles

Adaptive modification of antiviral defense systems in microbial community under Cr-induced stress.

Huang D, Liao J, Balcazar J, Ye M, Wu R, Wang D Microbiome. 2025; 13(1):34.

PMID: 39891205 PMC: 11786475. DOI: 10.1186/s40168-025-02030-z.


De Novo Assembly of the Polyhydroxybutyrate (PHB) Producer Strain H1 Genome and Genomic Analysis of PHB Production Machinery.

Traversa D, Pazzani C, DAddabbo P, Trisolini L, Chiara M, Oliva M Microorganisms. 2025; 13(1).

PMID: 39858905 PMC: 11767486. DOI: 10.3390/microorganisms13010137.


Endogenous Type I-C CRISPR-Cas system of subsp. promotes biofilm formation and pathogenicity.

Xie H, Zhang R, Li Z, Guo R, Li J, Fu Q Front Microbiol. 2024; 15:1417993.

PMID: 38841053 PMC: 11150851. DOI: 10.3389/fmicb.2024.1417993.

References
1.
Westra E, Buckling A, Fineran P . CRISPR-Cas systems: beyond adaptive immunity. Nat Rev Microbiol. 2014; 12(5):317-26. DOI: 10.1038/nrmicro3241. View

2.
Levy A, Goren M, Yosef I, Auster O, Manor M, Amitai G . CRISPR adaptation biases explain preference for acquisition of foreign DNA. Nature. 2015; 520(7548):505-510. PMC: 4561520. DOI: 10.1038/nature14302. View

3.
Ratner H, Sampson T, Weiss D . I can see CRISPR now, even when phage are gone: a view on alternative CRISPR-Cas functions from the prokaryotic envelope. Curr Opin Infect Dis. 2015; 28(3):267-74. PMC: 4414917. DOI: 10.1097/QCO.0000000000000154. View

4.
Guan J, Wang W, Sun B . Chromosomal Targeting by the Type III-A CRISPR-Cas System Can Reshape Genomes in . mSphere. 2017; 2(6). PMC: 5687920. DOI: 10.1128/mSphere.00403-17. View

5.
Citorik R, Mimee M, Lu T . Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol. 2014; 32(11):1141-5. PMC: 4237163. DOI: 10.1038/nbt.3011. View